At Rosemont our mission is to be a rapid developer, reliable manufacturer and global supplier of novel-delivery, patient-focused medicines.

Our ambition has always been to support both patients with swallowing difficulties and the healthcare professionals who care for them. We are highly respected in the industry and have been instrumental in establishing best practice for the care of patients with swallowing difficulties. Rosemont advocate the use of liquid medication over manipulating solid dose medications and we have a range of educational materials designed for healthcare professionals which focuses on key patient groups and their medication management challenges.  

At Rosemont we have a portfolio of over 130 oral liquid medicines across a range of therapeutic areas including 70 licensed products. All of our products, both licensed and ‘specials’ are made to the same exacting standards under GMP. Our UK range also includes 9 products licensed for use with PEG/NG tubes. We are always seeking to expand our range of medicines and covert our ‘specials’ to licensed product wherever possible.

Health Care

Pharmaceutical

Therapeutics

Rosemont Pharmaceuticals

Howard Taylor

Simon Nicklin

Deirdre O.

Jingle Pappachan

Janet MacLean

Tim Busby

Ed Cahill

Matthew Usher

Jacqueline Bonam

Neil Brown

Mark Vallance

Sharon Tucker

The Leadership Team at Rosemont Pharmaceuticals drives the strategic vision and operational excellence of the company. Comprising key executives from various disciplines, they collaborate to ensure the rapid development and reliable manufacturing of patient-focused liquid medications while upholding high industry standards. Their leadership fosters innovation, regulatory compliance, and organizational growth, ultimately enhancing patient care for those with swallowing difficulties.

Leadership Team

Quality Assurance Team

Marketing and Sales Team

Leadership Team

About

Team members

Other teams at Rosemont Pharmaceuticals

Quality Assurance Team

Marketing and Sales Team